Rocket Lab Corporation (RKLB)
RKLB Outperforms Industry in the Past Year: How to Play the Stock?
Rocket Lab surges 168.7% in a year on launch execution and Neutron progress, but premium valuation and rising costs raise questions about sustainability.
Rocket Lab: Neutron Setback, Now An Opportunistic Rating Upgrade To Buy
Rocket Lab is upgraded to buy, following a sharp price retreat and opportunistic entry point ahead of Q4 earnings. Neutron rocket schedule setbacks persist, with the first launch now likely delayed to late 2026 or early 2027, raising execution risk. Valuation now shows around 3% upside for 2030, with shares still overvalued on near-term earnings but supported by long-term growth positioning.
Rocket Lab Q4 Earnings Preview: Even A Beat Won't Save The Stock (Downgrade)
Rocket Lab is approaching Q4 earnings with strong recent execution, but the January Stage 1 tank rupture introduces high-probability schedule risk for Neutron's debut. Q4 revenue expectations look beatable because Neutron issues won't affect reported results, and Space Systems mix near 70% supports margin-driven EPS upside. The real risk is forward guidance: a Neutron delay could force long-tail consensus revisions and compress the valuation premium embedded in RKLB's stock price.
Rocket Lab Corporation (RKLB) Falls More Steeply Than Broader Market: What Investors Need to Know
The latest trading day saw Rocket Lab Corporation (RKLB) settling at $73.11, representing a -10.04% change from its previous close.
SpaceX IPO's $700 Billion Valuation Increase Benchmarked By Rocket Lab
SpaceX now has a potential $1.5 trillion IPO valuation targeted for mid-2026, an increase of nearly $700 billion in ~1 month. The valuation expansion is well supported by secular tailwinds, including a new Executive Order favor SPACE's commercialization of LEO and accelerated lunar projects. SpaceX is better positioned to capitalize on many of the space initiatives than RKLB, yet the valuation premium in terms of P/S ratios is quite mild.
Rocket Lab Stock: Why It's Dropping And What Comes Next
Rocket Lab Stock: Why It's Dropping And What Comes Next
Analysts Remain Steadfast on Rocket Lab After Neutron Test Failure
Shares of Rocket Lab NASDAQ: RKLB have pulled back sharply over the past week, closing Monday, Jan. 26, nearly 20% below its recent all-time high. The sell-off came despite continued momentum across the aerospace and defense sector and a recent successful Electron mission.
Space Stock Boom: Why Retail and Wall Street Are Aligning
For the last five years, the narrative between retail and institutional investors has been one of battle. Retail traders chased hype, while institutions stuck to the numbers.
Rocket Lab Corporation (RKLB) Exceeds Market Returns: Some Facts to Consider
Rocket Lab Corporation (RKLB) closed at $88.9 in the latest trading session, marking a +1.05% move from the prior day.
Rocket Lab's Stock Implodes Alongside Its Neutron Rocket. Time to Sell?
Rocket Lab ( NASDAQ:RKLB ) disclosed last night that qualification testing of the Stage 1 tank for its Neutron medium-lift rocket resulted in a rupture during a hydrostatic pressure trial.
Rocket Lab Gets a Big Upgrade: Will Upside Follow?
Shares of Rocket Lab NASDAQ: RKLB received another major vote of confidence this month after financial heavyweight Morgan Stanley significantly upgraded both its rating and price target on the stock. On Jan. 16, 2026, the firm raised its rating from Equal Weight to Overweight and lifted its price target from $67 to a Street-high $105.
Why Rocket Lab Stock Jumped 50%?
Rocket Lab (RKLB)'s stock surged 45%, in the past three months, driven not only by a robust 10% increase in revenue but also by a significant 36% uplift in valuation.
